This 2015 news article in Science discusses findings from a study by Yun et al., which demonstrated that high-dose vitamin C selectively kills colorectal cancer cells harboring KRAS or BRAF mutations. The mechanism involves vitamin C entering cancer cells as dehydroascorbic acid (DHA) via GLUT1 transporters. Inside the cell, DHA
